Cite
HARVARD Citation
Matsumoto, K. et al. (2020). A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide. Cancer medicine. pp. 3319-3327. [Online].